Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

DAXOR CORP (DXR)

Michel Robert J — Chief Financial Officer
Mar 31, 2026
Purchase
Shares
1,000
Price
$9.90
Total Value
$9.90K
Shares Held After
21,050
% of Holdings
4.8%

Zenas BioPharma, Inc. (ZBIO)

Lu Hongbo — Director
Mar 31, 2026
Purchase
Shares
75,000
Price
$20.00
Total Value
$1.50M
Shares Held After
422,968
% of Holdings
17.7%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Mar 31, 2026
Sale
Shares
67,991
Price
$4.88
Total Value
$331.80K
Shares Held After
431,094
% of Holdings
13.6%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Mar 31, 2026
Sale
Shares
3,639
Price
$65.00
Total Value
$236.53K
Shares Held After
66,004
% of Holdings
5.2%
Mar 30, 2026
Purchase
Shares
10,000
Price
$2.85
Total Value
$28.50K
Shares Held After
414,462
% of Holdings
2.4%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
2,334,420
Price
$3.30
Total Value
$7.70M
Shares Held After
12,262,741
% of Holdings
16.0%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
23,789
Price
$3.30
Total Value
$78.50K
Shares Held After
423,984
% of Holdings
5.3%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
38,976
Price
$3.30
Total Value
$128.62K
Shares Held After
302,213
% of Holdings
11.4%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
47,101
Price
$3.30
Total Value
$155.43K
Shares Held After
519,061
% of Holdings
8.3%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
168,794
Price
$3.30
Total Value
$557.02K
Shares Held After
1,425,544
% of Holdings
10.6%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
426,199
Price
$3.30
Total Value
$1.41M
Shares Held After
3,358,917
% of Holdings
11.3%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
50,797
Price
$3.30
Total Value
$167.63K
Shares Held After
425,732
% of Holdings
10.7%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
152,063
Price
$3.30
Total Value
$501.81K
Shares Held After
1,463,571
% of Holdings
9.4%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
370,847
Price
$3.30
Total Value
$1.22M
Shares Held After
3,238,210
% of Holdings
10.3%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
50,797
Price
$3.30
Total Value
$167.63K
Shares Held After
426,695
% of Holdings
10.6%

PRECIGEN, INC. (PGEN)

KIRK RANDAL J — Director
Mar 30, 2026
Sale
Shares
1,108,998
Price
$3.30
Total Value
$3.66M
Shares Held After
80,672,818
% of Holdings
1.4%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Mar 30, 2026
Sale
Shares
15,536
Price
$5.10
Total Value
$79.23K
Shares Held After
499,085
% of Holdings
3.0%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Mar 30, 2026
Sale
Shares
19,638
Price
$150.98
Total Value
$2.96M
Shares Held After
51,871
% of Holdings
27.5%

Polyrizon Ltd. (PLRZ)

Carmel Liron — Director
Mar 30, 2026
Sale
Shares
100
Price
$11.00
Total Value
$1.10K
Shares Held After
4,069
% of Holdings
2.4%
Mar 30, 2026
Purchase
Shares
58,300
Price
$24.16
Total Value
$1.41M
Shares Held After
5,825,521
% of Holdings
1.0%

Polyrizon Ltd. (PLRZ)

Turgeman Tidhar — Director
Mar 30, 2026
Sale
Shares
2,917
Price
$10.90
Total Value
$31.80K
Shares Held After
17,518
% of Holdings
14.3%

Polyrizon Ltd. (PLRZ)

Izraeli Tomer — Director
Mar 30, 2026
Sale
Shares
3,900
Price
$10.90
Total Value
$42.51K
Shares Held After
32,012
% of Holdings
10.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
21
Price
$606.53
Total Value
$12.74K
Shares Held After
18,876
% of Holdings
0.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
770
Price
$604.64
Total Value
$465.57K
Shares Held After
18,897
% of Holdings
3.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
103
Price
$603.69
Total Value
$62.18K
Shares Held After
19,667
% of Holdings
0.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
417
Price
$602.53
Total Value
$251.26K
Shares Held After
19,770
% of Holdings
2.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
212
Price
$601.43
Total Value
$127.50K
Shares Held After
20,187
% of Holdings
1.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
790
Price
$599.82
Total Value
$473.86K
Shares Held After
20,399
% of Holdings
3.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
200
Price
$598.83
Total Value
$119.77K
Shares Held After
21,189
% of Holdings
0.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
240
Price
$597.72
Total Value
$143.45K
Shares Held After
21,389
% of Holdings
1.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
204
Price
$596.74
Total Value
$121.74K
Shares Held After
21,629
% of Holdings
0.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
500
Price
$595.91
Total Value
$297.96K
Shares Held After
21,833
% of Holdings
2.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
480
Price
$594.74
Total Value
$285.47K
Shares Held After
22,333
% of Holdings
2.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
176
Price
$593.68
Total Value
$104.49K
Shares Held After
22,813
% of Holdings
0.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
120
Price
$592.12
Total Value
$71.05K
Shares Held After
22,989
% of Holdings
0.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
481
Price
$591.26
Total Value
$284.40K
Shares Held After
23,109
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
1,026
Price
$590.36
Total Value
$605.71K
Shares Held After
23,590
% of Holdings
4.2%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
1,196
Price
$589.23
Total Value
$704.72K
Shares Held After
24,616
% of Holdings
4.6%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
1,487
Price
$588.42
Total Value
$874.97K
Shares Held After
25,812
% of Holdings
5.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
860
Price
$587.35
Total Value
$505.12K
Shares Held After
27,299
% of Holdings
3.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
437
Price
$586.27
Total Value
$256.20K
Shares Held After
28,159
% of Holdings
1.5%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
120
Price
$585.17
Total Value
$70.22K
Shares Held After
28,596
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
120
Price
$583.52
Total Value
$70.02K
Shares Held After
28,716
% of Holdings
0.4%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
Mar 30, 2026
Sale
Shares
40
Price
$581.73
Total Value
$23.27K
Shares Held After
28,836
% of Holdings
0.1%

ASSEMBLY BIOSCIENCES, INC. (ASMB)

White Nicole S — Chief Manufacturing Officer
Mar 30, 2026
Sale
Shares
9
Price
$27.49
Total Value
$247.41
Shares Held After
37,477
% of Holdings
0.0%

ASSEMBLY BIOSCIENCES, INC. (ASMB)

White Nicole S — Chief Manufacturing Officer
Mar 30, 2026
Sale
Shares
188
Price
$26.65
Total Value
$5.01K
Shares Held After
37,486
% of Holdings
0.5%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Mar 30, 2026
Sale
Shares
2,839
Price
$28.55
Total Value
$81.06K
Shares Held After
159,914
% of Holdings
1.7%

Rapport Therapeutics, Inc. (RAPP)

Gault Cheryl — Chief Operating Officer
Mar 30, 2026
Sale
Shares
7,161
Price
$28.04
Total Value
$200.80K
Shares Held After
162,753
% of Holdings
4.2%
Mar 30, 2026
Sale
Shares
16
Price
$27.49
Total Value
$439.84
Shares Held After
11,089
% of Holdings
0.1%
Mar 30, 2026
Sale
Shares
312
Price
$26.65
Total Value
$8.31K
Shares Held After
11,105
% of Holdings
2.7%
Version: v26.3.33